- Care model
- Individualized telemedicine
- Contract
- No subscriptions or contracts advertised
- Assessment
- Laboratory and symptom review described
- Product evidence
- A 9 mg lyophilized sermorelin vial is listed
- Pricing
- Current complete quote required
- Follow-up
- Regular follow-up and portal ordering described
An itemized model requires a different comparison
Defy Medical describes peptide care as part of an individualized telemedicine service, combining symptom assessment, laboratory work when needed and follow-up. Its peptide page says it does not require subscriptions or contracts. That is a different financial structure from a fixed monthly medication bundle: the relevant comparison is the complete sequence of assessment, prescription ordering and reassessment.
The absence of a subscription does not establish a lower total cost. It may give a patient more visibility into separate purchases, but those purchases still need to be priced and scheduled before a realistic budget is possible.
There is a real product listing behind the category
The current peptide page specifically includes sermorelin. Defy's pharmacy storefront also lists a 9 mg lyophilized sermorelin acetate vial. That corroborates a concrete product rather than relying solely on a broad “peptide therapy” service description. We do not quote a current price for that vial because the reviewed public listing does not establish a usable current purchase amount.
An older provider PDF contains historical vial prices. Reusing those figures as today's price would create false precision, so a new quote must come from the current ordering process.
Ask how consultations and testing connect
Defy advertises extended consultations and regular follow-up. Ask which appointment type applies to a new sermorelin patient, how much it costs and whether existing laboratory records can be reviewed. If fresh tests are needed, the quote should identify the panel and the party that bills for it.
It is also useful to understand who reviews results and how the next clinical decision is made. A portal can make ordering convenient, but the availability of a refill button does not by itself explain when medical reassessment is required or how prescription changes are approved.
Keep the particular peptide in view
The service page discusses a range of peptides with different proposed purposes and evidence bases. Those descriptions should not be treated as one shared body of clinical proof. A study or claim about recovery associated with another peptide cannot establish what a particular sermorelin prescription will do.
Likewise, the page's discussion of combining peptide care with other services is not a recommendation that a reader add treatments. Tell the clinician about existing prescriptions and ask for the reason each proposed component belongs in the plan. More components mean more questions about cost, monitoring and attribution of effects.
What a useful Defy quote looks like
Request a document that separates initial consultation, any laboratory charges, medication quantity, supplies, shipping and planned follow-up. For the lyophilized vial, ask whether all necessary preparation supplies are included and obtain instructions directly from the pharmacist; the product name is not enough to work out use or duration.
Defy is a relevant option for readers comparing a consultation-led model with subscriptions. The choice should turn on the actual care needed and the complete quote, not an old vial price. Compounded prescriptions are not FDA-approved, and an individualized service model does not remove the need to discuss the evidence and risks for the specific treatment.
Useful distinctions
- No subscriptions or contracts advertised
- Individualized consultations and follow-up described
- Specific sermorelin vial listing available
Limitations to weigh
- No verified current all-in price
- Separate services require an itemized budget
- Historical PDF prices may be outdated
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.